162 related articles for article (PubMed ID: 34062954)
1. Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (
Liu W; Cao Y; Lin Y; Tan KS; Zhao H; Guo H; Tan W
Biology (Basel); 2021 May; 10(5):. PubMed ID: 34062954
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Contextual Fear Memory and Elevated Astroglial Glutamate Synthase Activity in Hippocampal CA1 BChE shRNA Knockdown Mice.
Chen S; Lin Z; Tan KL; Chen R; Su W; Zhao H; Tan Q; Tan W
Front Psychiatry; 2020; 11():564843. PubMed ID: 33061920
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
Bosak A; Gazić I; Vinković V; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
[TBL] [Abstract][Full Text] [Related]
5. Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse.
Maurice T; Strehaiano M; Siméon N; Bertrand C; Chatonnet A
Behav Brain Res; 2016 Jan; 296():351-360. PubMed ID: 26306824
[TBL] [Abstract][Full Text] [Related]
6. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
7. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
8. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
9. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline.
Kovarik Z; Simeon-Rudolf V
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):113-7. PubMed ID: 15449725
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.
Pistolozzi M; Du H; Wei H; Tan W
Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
Jasiecki J; Wasąg B
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
[No Abstract] [Full Text] [Related]
12. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Minic J; Chatonnet A; Krejci E; Molgó J
Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
[TBL] [Abstract][Full Text] [Related]
13. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
14. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
17. Bone status of adult female butyrylcholinesterase gene-deficient mice.
Haupt M; Kauschke V; Sender J; Kampschulte M; Kovtun A; Dürselen L; Heiss C; Lips KS
Int Immunopharmacol; 2015 Nov; 29(1):208-14. PubMed ID: 26138460
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive behavioral phenotyping of a new Semaphorin 3 F mutant mouse.
Matsuda I; Shoji H; Yamasaki N; Miyakawa T; Aiba A
Mol Brain; 2016 Feb; 9():15. PubMed ID: 26856818
[TBL] [Abstract][Full Text] [Related]
19. Willughbeia cochinchinensis prevents scopolamine-induced deficits in memory, spatial learning, and object recognition in rodents.
Can MV; Tran AH; Pham DM; Dinh BQ; Le QV; Nguyen BV; Nguyen MTT; Nguyen HX; Nguyen NT; Nishijo H
J Ethnopharmacol; 2018 Mar; 214():99-105. PubMed ID: 28652013
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice.
Dong Y; Li S; Lu Y; Li X; Liao Y; Peng Z; Li Y; Hou L; Yuan Z; Cheng J
J Neuroinflammation; 2020 Jul; 17(1):205. PubMed ID: 32635937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
